How much does Tirzepatide cost per tube or box?

Tirzepatide (Tirzepatide), as a new type of diabetes and weight management treatment drug, has not yet been officially launched in China. Therefore, patients cannot directly purchase the drug in domestic pharmacies for the time being. For patients who urgently need the drug, the main way is to obtain it through formal overseas channels to ensure that the source of the drug is regular, safe, and meets the usage standards.

Currently in overseas markets, the original drug of tilsiparatide is produced by Eli Lilly (Eli Lilly) and has been approved for marketing in some countries such as the United States and Europe. According to market information, the price of one European version of tilsiparatide injection (common specifications such as 5mg, 10mg or 15mg) is generally between 3,000 and 4,000 yuan, and the specific price will vary slightly due to exchange rate fluctuations and regional differences. This price is relatively high, partly because the drug is an innovative dual receptor agonist with high research and development costs and clinical value.

Although the price is not low, many users have reported that tilsiparatide has a significant effect in controlling blood sugar and weight. Especially for some obese patients with type 2 diabetes, the comprehensive benefits of the drug may be significantly better than traditional drugs. Therefore, some patients are willing to bear higher costs and choose to purchase through overseas channels for long-term management in individualized treatment plans.

In general, as an innovative drug that has not yet entered the domestic market, the current price of tilsiparatide remains at RMB 3,000 or 4,000 per vial. For patients, they should purchase through legal and formal channels, avoid using drugs from unknown sources, and use drugs rationally under the guidance of doctors to ensure efficacy and safety. In the future, if the drug is approved for marketing in China and included in medical insurance, the price is expected to drop further, benefiting more patients.

Reference materials:https://www.drugs.com/tirzepatide.html